Clin2
NCT07047508Possibly a fitNot yet recruiting

Jardiance study for heart failure with preserved pumping function

Heart FailurePreserved Ejection Fraction

Part of Heart & circulation clinical trials.

This study looks at how well the medicine Jardiance works and how safe it is for people with a certain type of heart failure where the heart's pumping function is only slightly reduced or preserved. It aims to help doctors understand the medicine's real-world effects in Chinese patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older.
  • You have had at least 6 months of medical records before starting the study.
  • You have a heart function test (LVEF) showing your heart pumps more than 40% (which is a sign of heart failure with preserved or mid-range ejection fraction).
  • You have high levels of a heart stress marker (NT-proBNP > 125 pg/mL or BNP ≥ 35 pg/mL).
  • You have been diagnosed with heart failure with preserved or mid-range ejection fraction, or chronic heart failure.
  • You are about to start or have recently started taking Jardiance for the first time (with no prior use in the last 6 months).
  • Your body mass index (BMI) is less than 45.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06517186Recruiting
Heart failure study with preserved pumping function

This study looks at how the heart muscle works in people with a type of heart failure where the heart pumps normally but doesn't fill properly. It aims to understand the cause better, which could lead to new treatments.

Chicago, Illinois
NCT07218627Recruiting· Phase 1
Study of an investigational medicine for heart failure

This study tests an experimental medicine called NNC0537-1482 for people with heart failure. It aims to see if the medicine helps improve symptoms and heart function.

London
NCT03951311Recruiting
Diet and lifestyle study for people with weaker heart pumping

This study looks at how metabolic changes, diet, and lifestyle patterns affect heart failure. It may help find ways to improve symptoms and health by targeting diet and daily habits.

Shanghai, Shanghai Municipality
NCT06931015Not yet recruiting
Staging heart failure with preserved pumping function

This study looks at a type of heart failure where the heart pumps normally but is too stiff to fill properly. It aims to better understand and classify this condition, which may help guide future treatments.

Moscow
NCT07044700Not yet recruiting
Jardiance compared with standard heart failure medicines in Chinese patients

This study looks at how well Jardiance (a medication for heart failure) works and how safe it is compared to other standard heart failure medicines in Chinese patients with a weak heart pump. It helps us understand which treatment works best in real life.

Beijing
NCT07795814Recruiting· Phase 2
Study of a new medicine for heart failure with preserved pumping function

This study tests an investigational medicine called EDG-15400 for people with a type of heart failure where the heart muscle is stiff and doesn't relax properly, even though the pumping function is normal. The goal is to see if the medicine improves symptoms and daily functioning.

Birmingham, Alabama

Hear when a new Heart failure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.